These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1923955)

  • 1. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas.
    Perrin G; Treluyer C; Trouillas J; Sassolas G; Goutelle A
    Pathol Res Pract; 1991 Jun; 187(5):587-92. PubMed ID: 1923955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
    Colao A; Di Sarno A; Guerra E; De Leo M; Mentone A; Lombardi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):200-10. PubMed ID: 16932285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant prolactinomas: clinical management and long-term follow up.
    Shrivastava RK; Arginteanu MS; King WA; Post KD
    J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
    Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
    Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of prolactinoma].
    Serri O; Somma M; Beauregard H; Rasio E; Comtois R; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):496-9. PubMed ID: 7905686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related differences in prolactin secretion in pituitary prolactinomas.
    Nishioka H; Haraoka J; Akada K; Azuma S
    Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
    Ahmed M; al-Dossary E; Woodhouse NJ
    Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of macroprolactinomas at Auckland Hospital 1975-91.
    Wallace EA; Holdaway IM
    N Z Med J; 1995 Feb; 108(994):50-2. PubMed ID: 7885646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of surgery for the treatment of prolactinomas.
    van't Verlaat JW
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():34-7. PubMed ID: 8103958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
    Sapunar J; López JM; Huete I; Tagle R
    Rev Med Chil; 1992 Feb; 120(2):168-73. PubMed ID: 1340555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactinoma in man: clinical and histological characteristics].
    Trouillas J; Delgrange E; Jouanneau E; Maiter D; Guigard MP; Donckier J; Perrin G; Jan M; Tourniaire J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):253-7. PubMed ID: 10970951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine.
    Mori H; Maeda T; Saitoh Y; Onishi T
    Pathol Res Pract; 1988 Sep; 183(5):580-3. PubMed ID: 3237547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.